Lead Biostatistician
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Candidates should have at least 2 years of experience in statistics or biostatistics, preferably within the medical or clinical research field. Proficiency in statistical programming tools such as STATA or R is required, along with knowledge of regulatory guidelines and CDISC standards preferred. Strong written and verbal communication skills are necessary, with the ability to explain statistical concepts to non-statisticians. The candidate must be able to work independently, manage their workload, and stay organized while demonstrating a passion for healthcare innovation.
The Biostatistician will assist in developing statistical methods and analysis plans for clinical trials across various therapeutic areas and phases. They will perform statistical programming tasks for the conduct and reporting of clinical trials and collaborate with Clinical Operations, Data Management, and other internal teams to provide statistical expertise and support for clinical trial design and execution. Additionally, they will communicate complex statistical results clearly to both technical and non-technical stakeholders.
Accelerates clinical trials for life sciences
Lindus Health focuses on speeding up clinical trials to help patients access new treatments more quickly. The company operates differently from traditional contract research organizations (CROs) by using a fixed-price model for studies and milestone-based payments, which aligns their incentives with those of their clients. Lindus Health combines a skilled clinical operations team with a specialized software platform and access to a vast database of 30 million Electronic Health Records. They handle all aspects of clinical studies, including designing the study, recruiting patients, capturing clinical data, monitoring progress, and managing projects. With their approach, Lindus Health has successfully assisted over 90 sponsors in conducting clinical trials across the US, UK, and Europe, completing them up to three times faster than conventional CROs and often delivering results ahead of schedule.